{"transactions":[{"id":4634424,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:18:55.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":38871,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":38871,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":38871},"source":{"system":"sec-edgar","filing":"0001878313-26-000099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000099/form4.xml","form_type":"4"}},{"id":718386,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:10:33.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":32003,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":32003,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":32003},"source":{"system":"sec-edgar","filing":"0001878313-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000070/form4.xml","form_type":"4"}},{"id":755128,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-02T13:01:25.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":1.336,"value":100200.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1519178,"source":{"system":"sec-edgar","filing":"0001878313-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000061/form4.xml","form_type":"4"}},{"id":819906,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:48:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":33099,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":33099,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":33099},"source":{"system":"sec-edgar","filing":"0001878313-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000029/form4.xml","form_type":"4"}},{"id":941133,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-12T13:44:30.000Z","date":"2024-05-01","kind":"gift","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These securities were beneficially owned by Mr. Smith through the Stan V Smith CUST Gage Quentin Smith IL UNIF TRNS MIN Act account.  On May 1, 2024, the shares were transferred to The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1444178,"source":{"system":"sec-edgar","filing":"0001878313-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000021/form4.xml","form_type":"4"}},{"id":941132,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-12T13:44:30.000Z","date":"2022-09-19","kind":"purchase","planned":false,"acquired":true,"shares":2700,"price":3.6884,"value":9958.68,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1424178,"source":{"system":"sec-edgar","filing":"0001878313-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000021/form4.xml","form_type":"4"}},{"id":951971,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:42:31.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":29216,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":29216,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":29216},"source":{"system":"sec-edgar","filing":"0001878313-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000016/form4.xml","form_type":"4"}},{"id":959785,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-23T13:18:50.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":57189,"price":1.36,"value":77777.04,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the sixth month anniversary of the issuance date and expire 3-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":57189,"derivative":{"exercise_price":1.36,"exercise_date":"2026-06-22","expiration_date":"2028-12-22","underlying":"Common Stock","underlying_shares":57189},"source":{"system":"sec-edgar","filing":"0001878313-25-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000073/form4.xml","form_type":"4"}},{"id":959784,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-23T13:18:50.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":57189,"price":1.224,"value":69999.336,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1421478,"source":{"system":"sec-edgar","filing":"0001878313-25-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000073/form4.xml","form_type":"4"}},{"id":976339,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-09T21:51:27.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":4580,"price":1.2,"value":5496.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are beneficially owned by Mr. Smith through the Blake Sarai Teitei Smith IL Unif Trns Min Act.  They are beneficially owned by Mr. Smith's family member.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4580,"source":{"system":"sec-edgar","filing":"0001878313-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000063/form4.xml","form_type":"4"}},{"id":976338,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-09T21:51:27.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":4580,"price":1.19,"value":5450.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through the Gage Quentin Smith IL Unif Trns Min Act.  They are beneficially owned by Mr. Smith's family member.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4580,"source":{"system":"sec-edgar","filing":"0001878313-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000063/form4.xml","form_type":"4"}},{"id":976337,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-09T21:51:27.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":4580,"price":1.1997,"value":5494.626,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are beneficially owned by Mr. Smith through the Travis Deo Zai Zai Smith IL Unif Trns Min Act.  They are beneficially owned by Mr. Smith's family member.  The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4580,"source":{"system":"sec-edgar","filing":"0001878313-25-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000063/form4.xml","form_type":"4"}},{"id":985227,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-01T11:14:55.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.0388,"value":15582.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.051, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1364289,"source":{"system":"sec-edgar","filing":"0001878313-25-000052","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000052/form4.xml","form_type":"4"}},{"id":987307,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-26T21:43:40.000Z","date":"2025-11-25","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.98,"value":14700.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9550 to $1.05, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1349289,"source":{"system":"sec-edgar","filing":"0001878313-25-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000045/form4.xml","form_type":"4"}},{"id":987306,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-26T21:43:40.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.99,"value":9900.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $0.9675 to $0.9899, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1334289,"source":{"system":"sec-edgar","filing":"0001878313-25-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000045/form4.xml","form_type":"4"}},{"id":1023450,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:33:37.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":24844,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":24844,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":24844},"source":{"system":"sec-edgar","filing":"0001878313-25-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000037/form4.xml","form_type":"4"}},{"id":1027532,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-10-02T20:51:47.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":19230,"price":1.57,"value":30191.1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on October 1, 2025.  The options are exercisable beginning on the six-month anniversary of the issuance date and expire 3-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":19230,"derivative":{"exercise_price":1.57,"exercise_date":"2026-04-01","expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":19230},"source":{"system":"sec-edgar","filing":"0001878313-25-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000019/form4.xml","form_type":"4"}},{"id":1027531,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-02T20:51:47.000Z","date":"2025-10-01","kind":"purchase","planned":false,"acquired":true,"shares":19230,"price":1.3,"value":24999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on October 1, 2025"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1324289,"source":{"system":"sec-edgar","filing":"0001878313-25-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000019/form4.xml","form_type":"4"}},{"id":1095575,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:14:56.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":24747,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":24747,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":24747},"source":{"system":"sec-edgar","filing":"0001127602-25-018653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018653/form4.xml","form_type":"4"}},{"id":1121529,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-06-05T20:42:27.000Z","date":"2025-06-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.71,"value":56999.43,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on June 3, 2025.  The options are exercisable beginning on the six-month anniversary of the issuance date and expire 5-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust dated 1993."}],"balance_after":33333,"derivative":{"exercise_price":1.71,"exercise_date":"2025-12-03","expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001127602-25-016869","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225016869/form4.xml","form_type":"4"}},{"id":1121528,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-05T20:42:27.000Z","date":"2025-06-03","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":1.5,"value":49999.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1305059,"source":{"system":"sec-edgar","filing":"0001127602-25-016869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225016869/form4.xml","form_type":"4"}},{"id":1152378,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-05-12T20:12:43.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":66666,"price":2.05,"value":136665.3,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":66666,"derivative":{"exercise_price":2.05,"exercise_date":"2026-05-08","expiration_date":"2031-05-08","underlying":"Common Stock","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001127602-25-013963","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013963/form4.xml","form_type":"4"}},{"id":1152377,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-12T20:12:43.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":66666,"price":1.5,"value":99999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 8, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1271726,"source":{"system":"sec-edgar","filing":"0001127602-25-013963","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225013963/form4.xml","form_type":"4"}},{"id":1175729,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:49:28.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are benefically owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":24800,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001127602-25-011819","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011819/form4.xml","form_type":"4"}},{"id":1222982,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:40:57.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.85,"value":46250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":25000,"derivative":{"exercise_price":1.85,"exercise_date":"2026-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-25-008327","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008327/form4.xml","form_type":"4"}},{"id":1222981,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:40:57.000Z","date":"2025-03-03","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.5,"value":37500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1205060,"source":{"system":"sec-edgar","filing":"0001127602-25-008327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008327/form4.xml","form_type":"4"}},{"id":1222980,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-03-05T21:39:20.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.87,"value":93500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This Form 4/A is being filed to correct the \"Date Exercisable\" and \"Expiration Date\" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 3 to \"February 24, 2025\"."},{"field":"shares","element":"transactionShares","label":"F4","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on February 24, 2025.  The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the inital issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":50000,"derivative":{"exercise_price":1.87,"exercise_date":"2026-02-24","expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-25-008322","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008322/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}},{"id":1222979,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-05T21:39:20.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.5,"value":75000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1180060,"source":{"system":"sec-edgar","filing":"0001127602-25-008322","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225008322/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-25"}},{"id":1246706,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-02-25T21:10:22.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.87,"value":93500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on February 24, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":50000,"derivative":{"exercise_price":1.87,"exercise_date":"2025-08-24","expiration_date":"2030-08-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-25-006574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225006574/form4.xml","form_type":"4"}},{"id":1246705,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-25T21:10:22.000Z","date":"2025-02-24","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.5,"value":75000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1180060,"source":{"system":"sec-edgar","filing":"0001127602-25-006574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225006574/form4.xml","form_type":"4"}},{"id":1315326,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-01-03T21:09:35.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":12782,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":12782,"derivative":{"exercise_price":1.98,"exercise_date":"2024-12-31","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":12782},"source":{"system":"sec-edgar","filing":"0001127602-25-000391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225000391/form4.xml","form_type":"4"}},{"id":1332563,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-12-13T22:17:59.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.08,"value":52000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":25000,"derivative":{"exercise_price":2.08,"exercise_date":"2025-06-13","expiration_date":"2030-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-24-029383","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224029383/form4.xml","form_type":"4"}},{"id":1332562,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-13T22:17:59.000Z","date":"2024-12-13","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.872,"value":46800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1130060,"source":{"system":"sec-edgar","filing":"0001127602-24-029383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224029383/form4.xml","form_type":"4"}},{"id":1377267,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-11-04T21:34:28.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.259,"value":225900.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":100000,"derivative":{"exercise_price":2.259,"exercise_date":"2025-05-01","expiration_date":"2030-05-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-24-026376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026376/form4.xml","form_type":"4"}},{"id":1377266,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-04T21:34:28.000Z","date":"2024-11-01","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.51,"value":251000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":957568,"source":{"system":"sec-edgar","filing":"0001127602-24-026376","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224026376/form4.xml","form_type":"4"}},{"id":1394765,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-10-02T20:54:08.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":9040,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are benefically owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":9040,"derivative":{"exercise_price":2.81,"exercise_date":"2024-09-30","expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":9040},"source":{"system":"sec-edgar","filing":"0001127602-24-024953","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224024953/form4.xml","form_type":"4"}},{"id":1463437,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-07-02T20:16:15.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":7160,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":7160,"derivative":{"exercise_price":3.42,"exercise_date":"2024-06-30","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":7160},"source":{"system":"sec-edgar","filing":"0001127602-24-019872","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224019872/form4.xml","form_type":"4"}},{"id":1534871,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-04-26T21:30:49.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":147492,"price":2.26,"value":333331.92,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":147492,"derivative":{"exercise_price":2.26,"exercise_date":"2024-10-25","expiration_date":"2029-10-25","underlying":"Common Stock","underlying_shares":147492},"source":{"system":"sec-edgar","filing":"0001127602-24-013488","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224013488/form4.xml","form_type":"4"}},{"id":1534870,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-26T21:30:49.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":147492,"price":2.03,"value":299408.76,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":1005060,"source":{"system":"sec-edgar","filing":"0001127602-24-013488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224013488/form4.xml","form_type":"4"}},{"id":1553965,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-04-02T21:01:33.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":11491,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnlogy, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficailly owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":11491,"derivative":{"exercise_price":2.2,"exercise_date":"2024-03-31","expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":11491},"source":{"system":"sec-edgar","filing":"0001127602-24-011901","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224011901/form4.xml","form_type":"4"}},{"id":1574978,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-03-15T23:11:19.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":170940,"price":1.3,"value":222222.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.  The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are beneficailly owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":170940,"derivative":{"exercise_price":1.3,"exercise_date":"2024-09-14","expiration_date":"2029-09-14","underlying":"Common Stock","underlying_shares":170940},"source":{"system":"sec-edgar","filing":"0001127602-24-010327","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224010327/form4.xml","form_type":"4"}},{"id":1574977,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-15T23:11:19.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":170940,"price":1.17,"value":199999.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":857568,"source":{"system":"sec-edgar","filing":"0001127602-24-010327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224010327/form4.xml","form_type":"4"}},{"id":1693272,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-01-04T02:07:17.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":19273,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":19273,"derivative":{"exercise_price":1.17,"exercise_date":"2023-12-31","expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":19273},"source":{"system":"sec-edgar","filing":"0001127602-24-000654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224000654/form4.xml","form_type":"4"}},{"id":1767928,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-10-03T20:05:49.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":10472,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":10472,"derivative":{"exercise_price":2.2,"exercise_date":"2023-09-30","expiration_date":"2033-09-30","underlying":"Common Stock","underlying_shares":10472},"source":{"system":"sec-edgar","filing":"0001127602-23-025141","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223025141/form4.xml","form_type":"4"}},{"id":1836809,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-07-05T12:11:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":11138,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":11138,"derivative":{"exercise_price":2.2,"exercise_date":"2023-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":11138},"source":{"system":"sec-edgar","filing":"0001127602-23-019766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223019766/form4.xml","form_type":"4"}},{"id":1911461,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-28T10:46:20.000Z","date":"2023-04-27","kind":"purchase","planned":false,"acquired":true,"shares":133300,"price":2.25,"value":299925.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":686628,"source":{"system":"sec-edgar","filing":"0001127602-23-013708","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223013708/form4.xml","form_type":"4"}},{"id":1915706,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-21T11:53:28.000Z","date":"2023-04-20","kind":"purchase","planned":true,"acquired":true,"shares":10000,"price":3.74,"value":37400.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.50 to $3.95, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":553328,"source":{"system":"sec-edgar","filing":"0001127602-23-013327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223013327/form4.xml","form_type":"4"}},{"id":1928965,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-04-04T10:36:24.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":7094,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":7094,"derivative":{"exercise_price":3.46,"exercise_date":"2023-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":7094},"source":{"system":"sec-edgar","filing":"0001127602-23-012021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223012021/form4.xml","form_type":"4"}},{"id":1937019,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-28T11:45:14.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":938,"price":3.49,"value":3273.62,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.26 to $3.60, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":543328,"source":{"system":"sec-edgar","filing":"0001127602-23-011434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223011434/form4.xml","form_type":"4"}},{"id":1939271,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-24T12:53:46.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":1862,"price":3.43,"value":6386.66,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.11 to $3.51, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":542390,"source":{"system":"sec-edgar","filing":"0001127602-23-011265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223011265/form4.xml","form_type":"4"}},{"id":1939270,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-24T12:53:46.000Z","date":"2023-03-22","kind":"purchase","planned":false,"acquired":true,"shares":1458,"price":3.18,"value":4636.44,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.07 to $3.39, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":540528,"source":{"system":"sec-edgar","filing":"0001127602-23-011265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223011265/form4.xml","form_type":"4"}},{"id":1941874,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-22T10:42:33.000Z","date":"2023-03-21","kind":"purchase","planned":false,"acquired":true,"shares":2736,"price":3.17,"value":8673.12,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.10 to $3.57 inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":539070,"source":{"system":"sec-edgar","filing":"0001127602-23-010968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223010968/form4.xml","form_type":"4"}},{"id":1941873,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-22T10:42:33.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":3006,"price":3.28,"value":9859.68,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.18 to $3.345 inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":536334,"source":{"system":"sec-edgar","filing":"0001127602-23-010968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223010968/form4.xml","form_type":"4"}},{"id":1957010,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T10:25:39.000Z","date":"2023-03-09","kind":"purchase","acquired":true,"shares":3582,"price":4.03,"value":14435.46,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.87 to $4.165, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":533328,"source":{"system":"sec-edgar","filing":"0001127602-23-009811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009811/form4.xml","form_type":"4"}},{"id":1961275,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-09T11:30:43.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":3076,"price":4.2,"value":12919.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.06 to $4.25 inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":529746,"source":{"system":"sec-edgar","filing":"0001127602-23-009534","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009534/form4.xml","form_type":"4"}},{"id":1961274,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-09T11:30:43.000Z","date":"2023-03-07","kind":"purchase","acquired":true,"shares":1961,"price":4.23,"value":8295.03,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.20 to $4.25 inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":526670,"source":{"system":"sec-edgar","filing":"0001127602-23-009534","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009534/form4.xml","form_type":"4"}},{"id":1966389,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-07T11:33:37.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":4594,"price":4.39,"value":20167.66,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.50 inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":524709,"source":{"system":"sec-edgar","filing":"0001127602-23-009205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009205/form4.xml","form_type":"4"}},{"id":1966388,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-07T11:33:37.000Z","date":"2023-03-03","kind":"purchase","acquired":true,"shares":2509,"price":4.43,"value":11114.87,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.39 to $4.50, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":520115,"source":{"system":"sec-edgar","filing":"0001127602-23-009205","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009205/form4.xml","form_type":"4"}},{"id":1974709,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-03T11:10:35.000Z","date":"2023-03-02","kind":"purchase","acquired":true,"shares":23,"price":4.41,"value":101.43,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":517606,"source":{"system":"sec-edgar","filing":"0001127602-23-008532","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223008532/form4.xml","form_type":"4"}},{"id":1974708,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-03T11:10:35.000Z","date":"2023-03-01","kind":"purchase","acquired":true,"shares":198,"price":4.48,"value":887.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.43 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":517583,"source":{"system":"sec-edgar","filing":"0001127602-23-008532","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223008532/form4.xml","form_type":"4"}},{"id":1984019,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-01T11:38:38.000Z","date":"2023-02-28","kind":"purchase","acquired":true,"shares":1619,"price":4.48,"value":7253.12,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $4.43 to $4.50, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":517385,"source":{"system":"sec-edgar","filing":"0001127602-23-007701","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223007701/form4.xml","form_type":"4"}},{"id":1984018,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-01T11:38:38.000Z","date":"2023-02-27","kind":"purchase","acquired":true,"shares":219,"price":4.47,"value":978.93,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.45 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":515766,"source":{"system":"sec-edgar","filing":"0001127602-23-007701","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223007701/form4.xml","form_type":"4"}},{"id":1996279,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-23T11:42:46.000Z","date":"2023-02-22","kind":"purchase","acquired":true,"shares":1073,"price":4.48,"value":4807.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.41 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":515547,"source":{"system":"sec-edgar","filing":"0001127602-23-006606","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006606/form4.xml","form_type":"4"}},{"id":1996278,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-23T11:42:46.000Z","date":"2023-02-21","kind":"purchase","acquired":true,"shares":228,"price":4.49,"value":1023.72,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.41 to $4.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":514474,"source":{"system":"sec-edgar","filing":"0001127602-23-006606","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006606/form4.xml","form_type":"4"}},{"id":2003862,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-21T11:58:15.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":75,"price":4.25,"value":318.75,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":514246,"source":{"system":"sec-edgar","filing":"0001127602-23-006047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006047/form4.xml","form_type":"4"}},{"id":2003861,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-21T11:58:15.000Z","date":"2023-02-16","kind":"purchase","acquired":true,"shares":62,"price":4.25,"value":263.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":514171,"source":{"system":"sec-edgar","filing":"0001127602-23-006047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223006047/form4.xml","form_type":"4"}},{"id":2011307,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-16T11:46:46.000Z","date":"2023-02-15","kind":"purchase","acquired":true,"shares":10,"price":4.25,"value":42.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":514109,"source":{"system":"sec-edgar","filing":"0001127602-23-005440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223005440/form4.xml","form_type":"4"}},{"id":2011306,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-16T11:46:46.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":198,"price":4.25,"value":841.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":514099,"source":{"system":"sec-edgar","filing":"0001127602-23-005440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223005440/form4.xml","form_type":"4"}},{"id":2016918,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-14T11:58:11.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":337,"price":4.25,"value":1432.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.24 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":513901,"source":{"system":"sec-edgar","filing":"0001127602-23-005031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223005031/form4.xml","form_type":"4"}},{"id":2043859,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-27T12:15:32.000Z","date":"2023-01-26","kind":"purchase","acquired":true,"shares":227,"price":4.24,"value":962.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.18 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":513564,"source":{"system":"sec-edgar","filing":"0001127602-23-002395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223002395/form4.xml","form_type":"4"}},{"id":2043858,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-27T12:15:32.000Z","date":"2023-01-25","kind":"purchase","acquired":true,"shares":9,"price":4.25,"value":38.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":513337,"source":{"system":"sec-edgar","filing":"0001127602-23-002395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223002395/form4.xml","form_type":"4"}},{"id":2068595,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-01-04T22:50:57.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":3807,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 30, 2022 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":3807,"derivative":{"exercise_price":3.51,"exercise_date":"2022-12-30","expiration_date":"2032-12-30","underlying":"Common Stock","underlying_shares":3807},"source":{"system":"sec-edgar","filing":"0001127602-23-000649","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000649/form4.xml","form_type":"4"}},{"id":2072891,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-03T12:42:22.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":500,"price":3.5,"value":1750.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":513328,"source":{"system":"sec-edgar","filing":"0001127602-23-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000002/form4.xml","form_type":"4"}},{"id":2072890,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-03T12:42:22.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":1471,"price":3.49,"value":5133.79,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.46 to $3.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":512828,"source":{"system":"sec-edgar","filing":"0001127602-23-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000002/form4.xml","form_type":"4"}},{"id":2075078,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-29T12:43:46.000Z","date":"2022-12-28","kind":"purchase","acquired":true,"shares":1266,"price":3.41,"value":4317.06,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.345 to $3.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":511357,"source":{"system":"sec-edgar","filing":"0001127602-22-028331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222028331/form4.xml","form_type":"4"}},{"id":2075077,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-29T12:43:46.000Z","date":"2022-12-27","kind":"purchase","acquired":true,"shares":604,"price":3.38,"value":2041.52,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.29 to $3.485 inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":510091,"source":{"system":"sec-edgar","filing":"0001127602-22-028331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222028331/form4.xml","form_type":"4"}},{"id":2076205,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-27T13:32:56.000Z","date":"2022-12-23","kind":"purchase","acquired":true,"shares":981,"price":3.45,"value":3384.45,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.35 to $3.50, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":509487,"source":{"system":"sec-edgar","filing":"0001127602-22-028285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222028285/form4.xml","form_type":"4"}},{"id":2076204,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-27T13:32:56.000Z","date":"2022-12-22","kind":"purchase","acquired":true,"shares":731,"price":3.34,"value":2441.54,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.25 to $3.42, inclusive.  The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":508506,"source":{"system":"sec-edgar","filing":"0001127602-22-028285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222028285/form4.xml","form_type":"4"}},{"id":2077808,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-22T13:00:29.000Z","date":"2022-12-21","kind":"purchase","acquired":true,"shares":399,"price":3.43,"value":1368.57,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.30 to $3.50, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":507775,"source":{"system":"sec-edgar","filing":"0001127602-22-028136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222028136/form4.xml","form_type":"4"}},{"id":2077807,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-22T13:00:29.000Z","date":"2022-12-20","kind":"purchase","acquired":true,"shares":4048,"price":3.53,"value":14289.44,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.42 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":507376,"source":{"system":"sec-edgar","filing":"0001127602-22-028136","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222028136/form4.xml","form_type":"4"}},{"id":2197924,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T22:41:53.000Z","date":"2022-08-01","kind":"other","acquired":true,"shares":7200,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with a crossover round with certain investors consisting of sales of common stock, $0.0001 par value per share (\"Common Stock\") of the Issuer at a price of $9.00 per share, in the event that the price per share of Common Stock sold in the IPO was less than $9.00 per share, the Issuer, on the closing date of the IPO (August 1, 2022), issued to such investors, so long as they continued to hold such shares of Common Stock purchased in the crossover round, that number of additional shares of Common Stock such that the price per share they paid in the crossover round was equal to the per share price in the Issuer's IPO. As the reporting person purchased 9,000 shares at $9.00 per share in the crossover round that the reporting person continued to hold, and the per share price in the IPO was $5.00 per share, accordingly, at the close of the IPO, the Issuer issued to the reporting person an additional 7,200 shares of Common Stock for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with a crossover round with certain investors consisting of sales of common stock, $0.0001 par value per share (\"Common Stock\") of the Issuer at a price of $9.00 per share, in the event that the price per share of Common Stock sold in the IPO was less than $9.00 per share, the Issuer, on the closing date of the IPO (August 1, 2022), issued to such investors, so long as they continued to hold such shares of Common Stock purchased in the crossover round, that number of additional shares of Common Stock such that the price per share they paid in the crossover round was equal to the per share price in the Issuer's IPO. As the reporting person purchased 9,000 shares at $9.00 per share in the crossover round that the reporting person continued to hold, and the per share price in the IPO was $5.00 per share, accordingly, at the close of the IPO, the Issuer issued to the reporting person an additional 7,200 shares of Common Stock for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":503328,"source":{"system":"sec-edgar","filing":"0000899243-22-027462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027462/doc4.xml","form_type":"4"}},{"id":2197923,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32976,"kind":"person","name":"Smith Stan","position":1,"cik":"0001913199","reported_name":"Smith Stan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T22:41:53.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":200000,"price":5,"value":1000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased in the initial public offering (the \"IPO\") of MAIA Biotechnology, Inc. (the \"Issuer\"), which closed on August 1, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."}],"balance_after":496128,"source":{"system":"sec-edgar","filing":"0000899243-22-027462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027462/doc4.xml","form_type":"4"}}]}